Free cash flow was negative in every one of the last ten quarters, averaging roughly -$17.2M in 2026 year-to-date versus -$11.4M in 2024, with cumulative operating outflows of $133.6M partly flattered by $20.4M of non-cash stock-based compensation addbacks.
Ocugen, Inc. (OCGN) cash flow statement — 14-year operating, investing & financing cash flows
| Metric | TTM | Dec'25 | Dec'24 | Dec'23 | Dec'22 | Dec'21 | Dec'20 | Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | Dec'13 | Dec'12 |
|---|
| Cash from Operations | -63.69M | -56.96M | -42.14M | -62.05M | -60.08M | -47.94M | -14.71M | -16.89M | -15.78M | -23.02M | -25.74M | -30.03M | -18.41M | -15.28M | -12.23M |
| Operating CF Margin % | - | -1290.82% | -1039.26% | -1028.06% | -2414.75% | - | -34206.35% | - | - | - | - | - | - | -191025% | -47046.15% |
| Operating CF Growth % | -83.4% | -35.17% | 32.09% | -3.29% | -25.32% | -225.94% | 12.93% | -7.08% | 31.46% | 10.55% | 14.31% | -63.18% | -20.44% | -24.93% | - |
| Net Income | -65.36M | -67.85M | -54.05M | -63.08M | -86.8M | -58.37M | -21.82M | -20.24M | -8.64M | -26.41M | -16.21M | -32.02M | -22.79M | -25.71M | -16.93M |
| Depreciation & Amortization | 1.33M | 2.39M | 1.97M | 704K | 480K | 229K | 102K | 61K | 49.62K | 1.53M | 1.67M | 1.61M | 726K | 566K | 638K |
| Stock-Based Compensation | 9.19M | 7.71M | 7.43M | 9.22M | 10.54M | 6.96M | 660K | 884.09K | 1.63M | 1.57M | 1.55M | 1.23M | 547K | 158K | 14K |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | -52K | 0 | 3.19M | -17.14M | 1.54M | -14.21M | 321K | 60K | 80K | 2.43M |
| Other Non-Cash Items | -10.32M | 1.31M | -1.15M | 4.26M | 6.51M | 799K | 7.56M | 2.33M | 11.13M | -543K | -533K | -322K | 672K | 8.36M | 1.57M |
| Working Capital Changes | 1.47M | -523K | 3.67M | -13.16M | 9.2M | 2.49M | -1.21M | -3.11M | -2.81M | -706K | 1.99M | -851K | 2.38M | 1.27M | 48K |
| Change in Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | -356K | 0 | 0 | 0 | 0 | 3.5M | -540.85M | -1.63B | -375K | -1.21M | -304K | -2.63M | 2.03M | 804K | -228K |
| Cash from Investing | -59.84M | -311K | -3.38M | 3.08M | -16.97M | -1.82M | -306.82K | -2.36M | -1.11M | -1.23M | -320K | -1.95M | -3.32M | -554K | -79K |
| Capital Expenditures | -211K | -185K | -3.38M | -10.48M | -4.46M | -939K | -306.82K | -29.45K | -2.01M | -276K | -320K | -1.95M | -3.32M | -604K | -79K |
| CapEx % of Revenue | 4.42% | 4.19% | 83.48% | 173.56% | 179.14% | - | 713.55% | - | - | - | - | - | - | 7550% | 303.85% |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -2.33M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | -126K | 0 | 0 | 761K | -877K | 0 | -273 | 0 | 0 | 0 | 0 | 0 | 50K | 0 |
| Cash from Financing | 115.52M | 17.33M | 64.86M | 20.88M | 59.48M | 120.68M | 31.61M | 25.07M | 25.35M | -577K | 27.05M | 4.37M | 71.05M | 9.85M | 26.69M |
| Debt Issued (Net) | -1.02M | -1M | 30M | 500K | 500K | -10K | -4.73M | 1.38M | -178K | -583K | -583K | -406K | 1.75M | 0 | 6.01M |
| Equity Issued (Net) | 24.35M | 18.33M | 38.56M | 20.45M | 59.57M | 129.21M | 37.82M | 23.68M | 25.53M | 0 | 27.63M | 4.74M | 70.76M | 10.26M | 20.68M |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -48K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 92.18M | 0 | -3.7M | -68K | -592K | -8.53M | -1.48M | 0 | 3K | 6K | 2K | 39K | -1.46M | -407K | 0 |
| Net Change in Cash | -7.93M | -39.93M | 19.36M | -38.1M | -17.55M | 70.92M | 16.6M | 5.82M | 8.46M | -24.83M | 993K | -27.61M | 49.33M | -5.98M | 14.38M |
| Free Cash Flow | -63.9M | -57.15M | -45.53M | -72.53M | -64.54M | -48.88M | -15.02M | -16.92M | -17.79M | -23.3M | -26.06M | -31.98M | -21.73M | -15.89M | -12.31M |
| FCF Margin % | -1337.16% | -1295.01% | -1122.74% | -1201.62% | -2593.89% | - | -34919.9% | - | - | - | - | - | - | -198575% | -47350% |
| FCF Growth % | -19.38% | -25.53% | 37.23% | -12.39% | -32.03% | -225.53% | 11.27% | 4.88% | 23.64% | 10.59% | 18.53% | -47.21% | -36.76% | -29.04% | - |
| FCF per Share | -0.19 | -0.19 | -0.17 | -0.30 | -0.30 | -0.25 | -0.13 | -1.22 | -28.78 | -61.66 | -108.65 | -145.03 | -849.73 | -74.72 | -57.90 |
| FCF Conversion (FCF/Net Income) | 0.98x | 0.84x | 0.78x | 0.98x | 0.69x | 0.82x | 0.67x | 0.83x | 1.83x | 0.87x | 1.59x | 0.94x | 0.81x | 0.59x | 0.72x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1K | 30K | 66K | 94K | 18K | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 105K | 197K | 257K | 79K | 2K | 0 | 0 |
Quick answers to the most common questions about buying OCGN stock.
Ocugen, Inc. (OCGN) generated $-57.0M in net cash from operating activities in 2025. This reflects the cash generated directly from core business operations.
Ocugen, Inc. (OCGN) reported negative free cash flow of $57.1M in 2025, indicating capital requirements exceeded cash from operations.
Ocugen, Inc. (OCGN) spent $0.2M on capital expenditures in 2025. CapEx represents the cash invested in physical assets like property, plant, and equipment to maintain or grow the business.
Key Metrics
Top Statement Risk
Persistent operating cash burn
Metrics are mathematically derived from official filings.
Non-Cash Charges Flatter Cash Burn
Across ten quarters, Ocugen's cumulative net losses of $166.0M exceed its cumulative operating cash outflow of $133.6M, an OCF/NI ratio swinging between 0.50 and 1.26, suggesting a material share of reported losses is non-cash rather than cash-consuming, according to SEC filings.
The gap is most visible in 2026Q2, where the net loss widened to -$24.9M while operating outflow narrowed to -$12.6M on a $6.3M working-capital release and $1.8M of stock-based compensation, implying the deeper headline loss was driven by below-the-line items rather than cash operations. The reverse occurred in 2026Q1, when the 1.14 ratio accompanied a -$6.6M working-capital swing, so conversion quality appears episodic rather than systematically conservative. Since both series are negative, the ratio should be read as a magnitude signal, not evidence of earnings quality in the conventional sense.
Free Cash Burn Widening
Ocugen's free cash flow was negative in all ten quarters, averaging roughly -$11.4M per quarter in 2024, -$14.3M in 2025 and -$17.2M in 2026 year-to-date, a widening trajectory that appears disconnected from its near-flat revenue line, based on Ocugen's reported figures.
Because capex is negligible, the FCF trajectory is effectively an operating-cost trajectory, meaning the worsening burn reflects expense growth rather than investment in future capacity. Reported FCF margins clustered between -7.4% and -14.2% except for 2025Q4, so the burn intensity against revenue has not improved despite five quarters of scale. Investors should monitor whether the 2026Q2 narrowing to -$12.6M persists or proves to be another working-capital-driven swing, as seen previously in 2024Q4 and 2025Q2.
Asset-Light Burn Skips Reinvestment
CapEx totalled only about $3.65M across ten quarters, falling from $2.4M in 2024Q1 to just $21K in 2026Q2, while cumulative depreciation of $5.5M ran ahead of capital spending, per Ocugen's cash flow disclosures.
The collapse in outlays means the CapEx/Revenue ratios of 44.6% and 45.0% in mid-2024 reflected a small denominator and a one-off spending pattern rather than structural capital intensity; more recent prints below 5% are the better run-rate. Depreciation exceeding capex by roughly $1.9M cumulatively suggests the existing asset base is being consumed faster than it is renewed, which is tolerable only if those assets are not revenue-generating. The implication is that essentially none of the $133.6M operating outflow has converted into productive capacity, concentrating the entire return question on commercial execution.
Liquidity Reserved, No Shareholder Returns
Ocugen returned no capital to shareholders across ten quarters, paying zero dividends and net repurchasing less than $0.5M of stock, while cumulative operating outflows reached $133.6M and no acquisition outlays were disclosed, per the cash flow statement.
Gross repurchases of approximately $390K were almost exactly offset by offsets in the opposite direction in 2024Q1, 2025Q1 and 2025Q1-adjacent periods, netting to effectively zero and suggesting share issuance activity rather than a deliberate buyback program. With no dividends, no acquisitions and near-zero capex, essentially all capital activity is being conserved to fund the operating burn, a posture that appears rational for a pre-commercial issuer but leaves no visible return on deployed capital to underwrite. Any change in this pattern, particularly a resumption of buybacks while losses deepen, would warrant a closer look at capital discipline.
Cumulative Gap Tracks Non-Cash Addbacks
Over the ten-quarter window Ocugen accumulated -$166.0M of net income against -$133.6M of operating cash flow, a $32.4M divergence that roughly matches the $20.4M of stock-based compensation and $5.5M of depreciation added back, as derived from the statement of cash flows.
The arithmetic suggests the divergence is explained predominantly by non-cash addbacks rather than by aggressive revenue recognition, which is the more common driver of a positive earnings-to-cash gap. However, the interpretation cuts both ways: $20.4M of stock-based compensation represents real economic cost delivered through dilution, so the cash shortfall understates the true cost of the loss period even though it does not drain the bank account. Investors should therefore treat the cumulative $133.6M outflow as the floor of value destruction, with dilution representing an additional, separately measured drag.
Addbacks and Margin Anomalies Warrant Scrutiny
Cumulative stock-based compensation of $20.4M is added back to operating cash flow without cash leaving the entity, an adjustment equal to roughly 15% of the $133.6M cumulative outflow that also dilutes shareholders, while a reported +72.5% FCF margin in 2025Q4 alongside -$14.0M of free cash flow appears internally inconsistent.
The 2025Q4 margin print is directionally impossible given negative FCF and should be verified against the underlying revenue figure before any margin trend is charted, since a similar distortion would invalidate the -7% to -14% range cited elsewhere. Beyond that, the cash flow statement provides no financing activities in the supplied series, so the runway funding the burn cannot be assessed from these data alone, and the classification of the small capex line as maintenance versus growth is immaterial at this scale but leaves no visibility into capitalized development costs. A short-seller would also note that quarter-to-quarter working-capital swings of +/- $6M, in a business with roughly $1.5M of quarterly revenue, are large relative to the top line and suggest collection or accrual timing that merits scrutiny.